Dixon Technologies Stock: Consolidated revenue went up by 52 per cent to Rs 4,658 crore against Rs 3,065 crore YoY. EBITDA rose 19.2 per cent to Rs 243 crore against Rs 204 crore YoY.
Ajanta Pharma has fixed May 30 as the record date for its buyback of 0.82% of the aggregate paid-up share capital of the company at Rs 2,770 per share. The pharma stock was trading at Rs 2,399.55, up 1% on BSE around 1:30 pm on Monday.
Adani Enterprises received two show cause notices (SCNs) from the Sebi over Hindenburg report in Q4FY24, alleging non-compliance of its provisions of the listing agreements and disclosure requirements (LODR regulations), the company stated in its filing to the exchanges, will keep stock in focus.